[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.128.52. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Other Articles
September 9, 1961

COMPLEMENT-FIXING ANTIBODIES IN HEALTHY SUBJECTS

JAMA. 1961;177(10):704. doi:10.1001/jama.1961.03040360040010
Abstract

Horror autotoxicus was the expression Ehrlich coined many years ago to characterize the presumed failure of the body to react, with antibody formation, to the antigenic stimulus of its own tissues. Yet more than 50 years ago Widal, Chauffard, and their associates noted autohemolysins in the blood in acquired hemolytic anemia, a finding rediscovered by Dameshek and Schwartz in 1938.1 In recent years, patients with acute viral infections and systemic lupus erythematosus have revealed high levels of complement-fixing substances against human tissue in their sera. The relationship between such apparently diverse illnesses and the antibodies in the sera has not been entirely clear.

Latterly, Muschel and associates2 reported that normal subjects may have antibodies in their sera which, in in vitro experiments, fix complement in the presence of a variety of normal animal and human tissues. These antibodies are found generally in lower titer in normal humans. Most

First Page Preview View Large
First page PDF preview
First page PDF preview
×